Advisors Asset Management, Inc. Repligen Corp Transaction History

Advisors Asset Management, Inc.

$5.28 Billion
Q3 2024

A detailed history of Advisors Asset Management, Inc. transactions in Repligen Corp stock. As of the latest transaction made, Advisors Asset Management, Inc. holds 9,091 shares of RGEN stock, worth $1.37 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

9,091

Previous 9,193 1.11%

Holding current value

$1.37 Million

Previous $1.16 Million 16.75%

% of portfolio

0.03%

Previous 0.02%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$119.79 - $167.35 $12,218 - $17,069	-102 Reduced 1.11%	9,091 $1.35 Million
Q2 2024 Aug 14, 2024	SELL	$120.0 - $182.95 $556,080 - $847,790	-4,634 Reduced 33.51%	9,193 $1.16 Million
Q1 2024 May 14, 2024	BUY	$170.78 - $208.42 $419,435 - $511,879	2,456 Added 21.6%	13,827 $2.54 Million
Q4 2023 Feb 14, 2024	SELL	$114.17 - $185.35 $97,158 - $157,732	-851 Reduced 6.96%	11,371 $2.04 Million
Q2 2023 Aug 14, 2023	SELL	$138.42 - $180.31 $408,615 - $532,275	-2,952 Reduced 19.45%	12,222 $1.73 Million
Q1 2023 May 12, 2023	SELL	$154.26 - $198.1 $126,647 - $162,640	-821 Reduced 5.13%	15,174 $2.55 Million
Q4 2022 Feb 13, 2023	SELL	$162.42 - $220.56 $690,122 - $937,159	-4,249 Reduced 20.99%	15,995 $2.71 Million
Q3 2022 Nov 08, 2022	SELL	$160.42 - $256.21 $44,115 - $70,457	-275 Reduced 1.34%	20,244 $3.79 Million
Q2 2022 Aug 08, 2022	SELL	$140.68 - $188.02 $296,412 - $396,158	-2,107 Reduced 9.31%	20,519 $3.33 Million
Q1 2022 May 17, 2022	SELL	$161.19 - $257.96 $316,899 - $507,149	-1,966 Reduced 7.99%	22,626 $4.26 Million
Q4 2021 Feb 15, 2022	SELL	$247.59 - $304.47 $239,667 - $294,726	-968 Reduced 3.79%	24,592 $6.51 Million
Q3 2021 Nov 12, 2021	SELL	$194.77 - $324.21 $521,788 - $868,558	-2,679 Reduced 9.49%	25,560 $7.39 Million
Q2 2021 Jul 30, 2021	SELL	$165.87 - $220.95 $9,454 - $12,594	-57 Reduced 0.2%	28,239 $5.64 Million
Q1 2021 May 07, 2021	BUY	$180.37 - $226.26 $510,807 - $640,768	2,832 Added 11.12%	28,296 $5.5 Million
Q4 2020 Feb 12, 2021	BUY	$148.08 - $206.57 $417,733 - $582,733	2,821 Added 12.46%	25,464 $4.88 Million
Q3 2020 Nov 16, 2020	BUY	$122.51 - $158.27 $472,031 - $609,814	3,853 Added 20.51%	22,643 $3.34 Million
Q2 2020 Aug 12, 2020	BUY	$94.33 - $140.48 $404,958 - $603,080	4,293 Added 29.61%	18,790 $2.32 Million
Q1 2020 May 15, 2020	BUY	$84.96 - $109.14 $316,306 - $406,328	3,723 Added 34.56%	14,497 $1.4 Million
Q4 2019 Feb 14, 2020	BUY	$73.84 - $93.08 $236,731 - $298,414	3,206 Added 42.36%	10,774 $994,000
Q3 2019 Nov 14, 2019	BUY	$76.65 - $95.51 $422,571 - $526,546	5,513 Added 268.27%	7,568 $580,000
Q2 2019 Aug 14, 2019	BUY	$54.2 - $85.95 $109,971 - $174,392	2,029 Added 7803.85%	2,055 $177,000
Q3 2017 Nov 07, 2017	BUY	$36.98 - $46.06 $961 - $1,197	26	26 $1,000

Others Institutions Holding RGEN

# of Institutions

489

Shares Held

54.3M

Call Options Held

341K

Put Options Held

235K

View Full List

About REPLIGEN CORP

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.35B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

More about RGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.

Account

Advisors Asset Management, Inc. Repligen Corp Transaction History